IBU Fundamental Analysis - IBU-TEC ADVANCED MATERIALS A

Fundamental Rating

Overall IBU gets a fundamental rating of 3 out of 10. We evaluated IBU against 69 industry peers in the Chemicals industry. IBU has a great financial health rating, but its profitability evaluates not so good. IBU does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year IBU has reported negative net income.

IBU had a positive operating cash flow in the past year.

In multiple years IBU reported negative net income over the last 5 years.

The reported operating cash flow has been mixed in the past 5 years: IBU reported negative operating cash flow in multiple years.

1.2 Ratios

IBU's Return On Assets of -7.69% is on the low side compared to the rest of the industry. IBU is outperformed by 79.71% of its industry peers.

IBU has a Return On Equity of -10.32%. This is in the lower half of the industry: IBU underperforms 72.46% of its industry peers.

		Industry Rank	Sector Rank
ROA	-7.69%
ROE	-10.32%
ROIC	N/A

ROA(3y)-3.09%

ROA(5y)-1.54%

ROE(3y)-4.18%

ROE(5y)-1.98%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

IBU has a Gross Margin of 46.34%. This is in the better half of the industry: IBU outperforms 66.67% of its industry peers.

In the last couple of years the Gross Margin of IBU has declined.

IBU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	46.34%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.97%

GM growth 5Y-1.86%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

IBU does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for IBU remains at a similar level compared to 1 year ago.

Compared to 5 years ago, IBU has more shares outstanding

Compared to 1 year ago, IBU has an improved debt to assets ratio.

2.2 Solvency

IBU has an Altman-Z score of 2.82. This is not the best score and indicates that IBU is in the grey zone with still only limited risk for bankruptcy at the moment.

Looking at the Altman-Z score, with a value of 2.82, IBU is in the better half of the industry, outperforming 68.12% of the companies in the same industry.

The Debt to FCF ratio of IBU is 2.92, which is a good value as it means it would take IBU, 2.92 years of fcf income to pay off all of its debts.

IBU has a better Debt to FCF ratio (2.92) than 89.86% of its industry peers.

A Debt/Equity ratio of 0.13 indicates that IBU is not too dependend on debt financing.

IBU has a better Debt to Equity ratio (0.13) than 84.06% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.13
Debt/FCF	2.92
Altman-Z	2.82

ROIC/WACCN/A

WACC6.96%

2.3 Liquidity

IBU has a Current Ratio of 7.42. This indicates that IBU is financially healthy and has no problem in meeting its short term obligations.

IBU has a Current ratio of 7.42. This is amongst the best in the industry. IBU outperforms 98.55% of its industry peers.

IBU has a Quick Ratio of 2.75. This indicates that IBU is financially healthy and has no problem in meeting its short term obligations.

The Quick ratio of IBU (2.75) is better than 95.65% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	7.42
Quick Ratio	2.75

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

IBU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -113.39%.

Looking at the last year, IBU shows a small growth in Revenue. The Revenue has grown by 4.93% in the last year.

IBU shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.88% yearly.

EPS 1Y (TTM)-113.39%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%24.75%

Revenue 1Y (TTM)4.93%

Revenue growth 3Y4.71%

Revenue growth 5Y0.88%

Sales Q2Q%12.48%

3.2 Future

Based on estimates for the next years, IBU will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.52% on average per year.

The Revenue is expected to grow by 0.65% on average over the next years.

EPS Next Y48.51%

EPS Next 2Y23.08%

EPS Next 3Y16.52%

EPS Next 5YN/A

Revenue Next Year-11%

Revenue Next 2Y-2.49%

Revenue Next 3Y0.65%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

IBU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IBU. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

IBU's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. IBU is more expensive than 73.91% of the companies in the same industry.

Based on the Price/Free Cash Flow ratio, IBU is valued a bit cheaper than 71.01% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	22.84
EV/EBITDA	58.04

4.3 Compensation for Growth

A more expensive valuation may be justified as IBU's earnings are expected to grow with 16.52% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y23.08%

EPS Next 3Y16.52%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

With a yearly dividend of 0.18%, IBU is not a good candidate for dividend investing.

IBU's Dividend Yield is slightly below the industry average, which is at 3.06.

Compared to an average S&P500 Dividend Yield of 2.34, IBU's dividend is way lower than the S&P500 average.

		Industry Rank	Sector Rank
Dividend Yield	0.18%

5.2 History

Dividend Growth(5Y)N/A

Div Incr Years0

Div Non Decr Years0

5.3 Sustainability

DP0%

EPS Next 2Y23.08%

EPS Next 3Y16.52%

More info and screens

Find the best dividend stocks

Show peers with best dividend

IBU-TEC ADVANCED MATERIALS A

FRA:IBU (8/22/2025, 7:00:00 PM)

11.2

+0.15 (+1.36%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)03-25 2025-03-25/amc

Earnings (Next)08-27 2025-08-27

Inst Owners3.82%

Inst Owner ChangeN/A

Ins Owners48.12%

Ins Owner ChangeN/A

Market Cap53.20M

Analysts45.71

Price Target7.75 (-30.8%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0.18%

Yearly Dividend0

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)2.7%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)32.35%

EPS NY rev (3m)32.35%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-17.79%

Revenue NY rev (3m)-17.79%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	1.05
P/FCF	22.84
P/OCF	5.71
P/B	1.03
P/tB	1.13
EV/EBITDA	58.04

EPS(TTM)-1.12

EYN/A

EPS(NY)-0.7

Fwd EYN/A

FCF(TTM)0.49

FCFY4.38%

OCF(TTM)1.96

OCFY17.51%

SpS10.66

BVpS10.82

TBVpS9.88

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-7.69%
ROE	-10.32%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	46.34%
FCFM	4.6%

ROA(3y)-3.09%

ROA(5y)-1.54%

ROE(3y)-4.18%

ROE(5y)-1.98%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.97%

GM growth 5Y-1.86%

F-Score4

Asset Turnover0.73

Health

		Industry Rank	Sector Rank
Debt/Equity	0.13
Debt/FCF	2.92
Debt/EBITDA	6.67
Cap/Depr	146.62%
Cap/Sales	13.81%
Interest Coverage	N/A
Cash Conversion	915.14%
Profit Quality	N/A
Current Ratio	7.42
Quick Ratio	2.75
Altman-Z	2.82

F-Score4

WACC6.96%

ROIC/WACCN/A

Cap/Depr(3y)170.7%

Cap/Depr(5y)144.35%

Cap/Sales(3y)15.86%

Cap/Sales(5y)13.92%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-113.39%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%24.75%

EPS Next Y48.51%

EPS Next 2Y23.08%

EPS Next 3Y16.52%

EPS Next 5YN/A

Revenue 1Y (TTM)4.93%

Revenue growth 3Y4.71%

Revenue growth 5Y0.88%

Sales Q2Q%12.48%

Revenue Next Year-11%

Revenue Next 2Y-2.49%

Revenue Next 3Y0.65%

Revenue Next 5YN/A

EBIT growth 1Y-108.91%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year183.78%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y147.35%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y286.44%

OCF growth 3YN/A

OCF growth 5Y17.1%

IBU-TEC ADVANCED MATERIALS A (IBU.DE) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens